ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. ImmunoCellular has concluded a phase 2 trial of its lead product candidate, ICT-107, a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. ImmunoCellular’s pipeline also includes: ICT-121, a dendritic cell immunotherapy targeting the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a dendritic cell immunotherapy targeting antigens on ovarian cancer stem cells; and the Stem-to-T-cell research program which engineers the patient’s hematopoietic stem cells to generate antigen-specific cancer-killing T-cells.
Company Details
- Employees
- 12
- Address
- 23622 Calabasas Rd., Suite 300, Calabasas,91302,united States
- Phone
- (818) 264-2300
- in****@****muc.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- imuc.com
- Keywords
- Immunotherapy.
- HQ
- Calabasas
Immunocellular Therapeutics Ltd Questions
Immunocellular Therapeutics Ltd's helpline number is (818) 264-2300
Immunocellular Therapeutics Ltd's website is imuc.com
Immunocellular Therapeutics Ltd's LinkedIn profile is https://www.linkedin.com/company/immunocellular-therapeutics-ltd
Immunocellular Therapeutics Ltd has
12 employees.
View email and phone details for 12
employees at Immunocellular Therapeutics Ltd.
Immunocellular Therapeutics Ltd's industry is
Biotechnology Research
Immunocellular Therapeutics Ltd's top competitors are
Entrogen, Inc.,
Imaginab,
Ring Therapeutics,
Jazz Pharmaceuticals,
Sarepta Therapeutics,
Resilience,
Fibrogen, Inc.,
Excellos,
Arcutis Biotherapeutics, Inc. (Nasdaq: Arqt),
Continuus Pharmaceuticals.
Immunocellular Therapeutics Ltd's support email address is info@imuc.com
Immunocellular Therapeutics Ltd's categories are Biotechnology Research
